Keywords: americans, understand, rx, risk/benefits, study, consumers, response

Americans understand Rx risk/benefits: study

Article | 14 March 2005

Print This

US consumers' response to concerns relating to the COX-2 inhibitors - Pfizer's Celebrex (celebrex) and Bextra (valdecoxib) and Merck & Co's ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in